+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Pentoxifylline, but not ursodeoxycholic acid or tauroursodeoxycholic acid inhibits the proliferative effect of sera samples from primary biliary cirrhosis patients



Pentoxifylline, but not ursodeoxycholic acid or tauroursodeoxycholic acid inhibits the proliferative effect of sera samples from primary biliary cirrhosis patients



Hepatology Research 7(2): 94-104




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062638776

Download citation: RISBibTeXText

DOI: 10.1016/s0928-4346(97)00025-x


Related references

Ursodeoxycholic acid inhibits eosinophil degranulation in patients with primary biliary cirrhosis. Hepatology 30(1): 71-78, 1999

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. Journal of Hepatology 18(1): 9-14, 1993

The effects of colchicine and methotrexate are additive to ursodeoxycholic acid for patients with primary biliary cirrhosis who respond incompletely to ursodeoxycholic acid. Hepatology 26(4 PART 2): 438A, 1997

Effect of ursodeoxycholic acid administration on primary bile acid kinetics in patients with primary biliary cirrhosis. Gastroenterology 100(5 PART 2): A772, 1991

Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone. Gastroenterologie Clinique et Biologique 34(4-5): 283-287, 2010

Changes induced by ursodeoxycholic acid udca administration on biliary and serum bile acid composition in patients with primary biliary cirrhosis pbc. Hepatology 12(4 PART 2): 995, 1990

Effect of ursodeoxycholic acid on biliary lipid secretion and bile acid metabolism in primary biliary cirrhosis. Hepatology 8(5): 1317, 1988

Comparison between tauroursodeoxycholic and ursodeoxycholic acids in patients with primary biliary cirrhosis A crossover study. Journal of Hepatology 26(SUPPL 1): 167, 1997

Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosis. Journal Of Hepatology. 18(3): 373-377, 1993

Cholesterol-lowering effect of ursodeoxycholic acid in patients with primary biliary cirrhosis. Hepatology. 17(4): 577-582, 1993

Effect of ursodeoxycholic acid on serum lipids of patients with primary biliary cirrhosis. O Clinic Proceedings. 69(10): 923-929, 1994

Ursodeoxycholic acid inhibits eosinophil degranulation in situ in primary biliary cirrhosis. Hepatology 28(4 PART 2): 542A, 1998

Serum cytokines in patients with primary biliary cirrhosis Effect of treatment with ursodeoxycholic acid. Gastroenterology 116(4 PART 2): A1239, April, 1999

CXCR3 axis in patients with Primary Biliary Cirrhosis A possible novel mechanism of the effect?of Ursodeoxycholic Acid. 2013

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. Journal of Hepatology 25(1): 49-57, 1996